The individual and societal prices of non-adherence to continuous positive airway pressure, contributors, and strategies for improvement.

Adherence continuous positive airway pressure couple data visualization obstructive sleep apnea socio-economic telemedicine

Journal

Expert review of respiratory medicine
ISSN: 1747-6356
Titre abrégé: Expert Rev Respir Med
Pays: England
ID NLM: 101278196

Informations de publication

Date de publication:
04 2023
Historique:
medline: 5 5 2023
pubmed: 13 4 2023
entrez: 12 4 2023
Statut: ppublish

Résumé

Continuous positive airway pressure (CPAP) is the first-line therapy for obstructive sleep apnea (OSA). CPAP is highly effective for improving symptoms and quality of life, but the major issue is adherence, with up to 50% of OSA discontinuing CPAP in the first 3 years after CPAP initiation. We present the individual and societal costs of non-adherence to CPAP, factors associated with non-adherence to CPAP, as well as current strategies for improving adherence including telehealth, couple-based interventions, and behavioral interventions. We also report on challenges and pitfalls for the visualization and analysis of CPAP remote monitoring platforms. CPAP termination rates and adherence to therapy remain major issues despite technical improvements in CPAP devices. The individual and societal price of non-adherence to CPAP for OSA patients goes beyond excessive sleepiness and includes cardiovascular events, all-cause mortality, and increased health costs. Strategies for improving CPAP adherence should be individually tailored and aim to also improve lifestyle habits including physical activity and diet. Access to these strategies should be supported by refining visualization dashboards of CPAP remote monitoring platforms, and by disseminating telehealth and innovative analytics, including artificial intelligence.

Identifiants

pubmed: 37045746
doi: 10.1080/17476348.2023.2202853
doi:

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

305-317

Auteurs

Monique Mendelson (M)

HP2 Laboratory, Inserm U1300, Grenoble Alps University, Grenoble, France.

Jeremy Duval (J)

HP2 Laboratory, Inserm U1300, Grenoble Alps University, Grenoble, France.
LVL Médical, 44 Quai Charles de Gaulle, Lyon, France.

François Bettega (F)

HP2 Laboratory, Inserm U1300, Grenoble Alps University, Grenoble, France.

Renaud Tamisier (R)

HP2 Laboratory, Inserm U1300, Grenoble Alps University, Grenoble, France.

Sébastien Baillieul (S)

HP2 Laboratory, Inserm U1300, Grenoble Alps University, Grenoble, France.

Sébastien Bailly (S)

HP2 Laboratory, Inserm U1300, Grenoble Alps University, Grenoble, France.

Jean-Louis Pépin (JL)

HP2 Laboratory, Inserm U1300, Grenoble Alps University, Grenoble, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH